Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.

BACKGROUND: Rimonabant is a selective type 1 cannabinoid (CB1) receptor antagonist. It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. Rimonabant also seeks to address many smokers' reluctance to pers...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Cahill, K, Ussher, M
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2007

Antzeko izenburuak